Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Total Liabilities (2016 - 2026)

Nutex Health (NUTX) has disclosed Total Liabilities for 17 consecutive years, with $515.3 million as the latest value for Q1 2026.

  • For Q1 2026, Total Liabilities rose 1.7% year-over-year to $515.3 million; the TTM value through Mar 2026 reached $515.3 million, up 1.7%, while the annual FY2025 figure was $495.1 million, 6.06% up from the prior year.
  • Total Liabilities hit $515.3 million in Q1 2026 for Nutex Health, up from $495.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $526.5 million in Q3 2025 and bottomed at $5.4 million in Q1 2023.
  • Average Total Liabilities over 5 years is $338.7 million, with a median of $340.4 million recorded in 2024.
  • Year-over-year, Total Liabilities plummeted 47.17% in 2023 and then soared 5905.03% in 2024.
  • Nutex Health's Total Liabilities stood at $311.4 million in 2022, then grew by 2.48% to $319.1 million in 2023, then surged by 46.26% to $466.8 million in 2024, then increased by 6.06% to $495.1 million in 2025, then grew by 4.08% to $515.3 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $515.3 million, $495.1 million, and $526.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.